Bank of New York Mellon Corp - ABEONA THERAPEUTICS INC ownership

ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 54 filers reported holding ABEONA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ABEONA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$9,000
-35.7%
44,0710.0%0.00%
Q1 2022$14,000
-6.7%
44,0710.0%0.00%
Q4 2021$15,000
-86.4%
44,071
-55.0%
0.00%
Q3 2021$110,000
-28.1%
97,8940.0%0.00%
Q2 2021$153,000
-70.3%
97,894
-64.3%
0.00%
Q1 2021$516,000
+17.0%
274,225
-2.3%
0.00%
Q4 2020$441,000
+65.8%
280,733
+7.6%
0.00%
Q3 2020$266,000
-66.1%
260,786
-3.0%
0.00%
Q2 2020$784,000
+49.6%
268,930
+8.0%
0.00%
Q1 2020$524,000
-19.6%
248,982
+24.6%
0.00%
Q4 2019$652,000
+95.8%
199,765
+36.0%
0.00%
Q3 2019$333,000
-56.1%
146,937
-7.4%
0.00%
Q2 2019$759,000
-26.2%
158,723
+13.6%
0.00%
Q1 2019$1,029,000
+3.1%
139,714
-0.0%
0.00%
Q4 2018$998,000
-45.4%
139,749
-2.1%
0.00%
Q3 2018$1,827,000
-19.3%
142,811
+0.9%
0.00%
-100.0%
Q2 2018$2,265,000
+10.9%
141,525
-0.6%
0.00%0.0%
Q1 2018$2,043,000
-34.0%
142,396
-27.2%
0.00%0.0%
Q4 2017$3,097,000
+76.4%
195,474
+89.8%
0.00%
Q3 2017$1,756,000
+174.4%
103,009
+3.0%
0.00%
Q2 2017$640,000
+204.8%
99,996
+138.5%
0.00%
Q1 2017$210,000
+133.3%
41,929
+125.8%
0.00%
Q4 2016$90,000
+69.8%
18,571
-9.8%
0.00%
Q1 2016$53,000
-15.9%
20,579
+10.3%
0.00%
Q4 2015$63,000
-14.9%
18,652
+1.6%
0.00%
Q3 2015$74,000
-43.9%
18,363
-29.8%
0.00%
Q2 2015$132,00026,1740.00%
Other shareholders
ABEONA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 1,359,767$3,481,0001.41%
DAFNA Capital Management LLC 181,818$465,0000.40%
Perceptive Advisors 1,762,881$4,512,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 468,050$1,198,0000.26%
Soros Fund Management 1,462,122$3,743,0000.08%
SABBY MANAGEMENT, LLC 334,108$855,0000.04%
KLCM Advisors, Inc. 28,612$73,0000.02%
CAMBRIDGE TRUST CO 65,414$167,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 35,400$91,0000.01%
IFP Advisors, Inc 10,000$74,0000.01%
View complete list of ABEONA THERAPEUTICS INC shareholders